海翔药业：公司参投的寓鑫基金分别持有天兵科技和爱思达航天的1.352%股权和2.83%股权

Group 1 - The core viewpoint of the article is that Haixiang Pharmaceutical (002099) has invested in the Yuxin Fund, which holds stakes in Tianbing Technology and Aisida Aerospace, with ownership percentages of 1.352% and 2.83% respectively [1] - Both Tianbing Technology and Aisida Aerospace have initiated IPO guidance, indicating potential future public offerings [1]